Ser285
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser285  -  NFAT3 (human)

Site Information
SSAsPALsRRGsLGE   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 13419501

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mass spectrometry (in vitro) ( 1 ) , mutation of modification site ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:
MEF (fibroblast) [RSK2 (human), homozygous knockout] ( 1 )

Upstream Regulation
Putative in vivo kinases:
RSK2 (human) ( 1 )
Kinases, in vitro:
RSK2 (human) ( 1 )

Downstream Regulation
Effects of modification on biological processes:
transcription, altered ( 1 )

References 

1

Cho YY, et al. (2007) RSK2 mediates muscle cell differentiation through regulation of NFAT3. J Biol Chem 282, 8380-92
17213202   Curated Info